Business Wire

CO-PRIETO-BATTERY,-INC.

22.5.2023 15:04:25 CEST | Business Wire | Press release

Share
Prieto Introduces World’s Fastest-Charging Battery That Charges in 3 Minutes

Prieto Battery, Inc., a world leader in advanced lithium-ion battery technology, unveiled the most recent prototype of its patented 3D interdigitated battery that delivers groundbreaking performance:

  • 3-minute hyper-fast charge
  • Operates and charges in extremely low (-30 degrees C) and high (+100 degrees C) temperatures
  • Nonflammable

All three attributes of Prieto’s lithium-ion battery were tested and validated by a third-party accredited battery testing lab.

Hyper-Fast Charge

“Prieto’s battery will charge faster than you can fill your car’s gas tank,” said Mike Rosenberg, Prieto CEO. “When you charge your car faster than gassing up, range is no longer a hindrance and everyone becomes a potential EV buyer.”

Due to its 3D architecture, Prieto’s battery fully charges in three minutes and achieves a 50% charge in 90 seconds, regardless of size.

“A three-minute charge fundamentally changes how companies can design their products and how consumers use them,” added Rosenberg.

All-Weather Extreme Temperature Operation

The Prieto 3D battery delivers the industry’s widest temperature operation. Not only does it operate at -30 degrees C (-22 degrees F), but it also charges at that temperature. The battery also operates and is safe at temperatures as high as +100 degrees C (212 degrees F).

“Prieto’s battery is the only battery that we are aware of that will not only operate, but will also charge at -30 degrees Celsius,” explained Rosenberg. “As we learned this past winter when extreme cold weather hit North America, many people were left stranded with dead EVs. Our battery would have allowed these EVs to continue to operate and charge, instilling confidence in drivers to rely on their EVs even in extreme temperatures.”

Nonflammable

Prieto’s 3D architecture and design ensure that the battery is not flammable or combustible. A third-party lab conducted the gold standard “nail penetration test” on Prieto’s battery that resulted in no fire or explosion, and the battery continued to operate.

“Prieto’s battery operates safely and will not catch fire like traditional lithium-ion batteries,” Rosenberg said. “The 3D architecture and the materials we use ensure that our batteries will not experience thermal runaways or fires, which gives consumers peace of mind.”

3D Interdigitated Technology

“Our founder, Dr. Amy Prieto, reimagined the entire architecture of a conventional battery and developed the first 3D interdigitated battery,” said Rosenberg. “We’re introducing a better architecture and a better process, which results in a better battery and a superior consumer experience. This is truly the next evolution that will redefine the way we power our lives.”

Prieto’s 3D architecture is completely different from all other batteries. Today’s batteries use a decades-old 2D architecture that must always compromise between energy storage and fast charging. In 2D batteries, energy can only flow in one direction across a two-dimensional plane. To charge, lithium ions must flow from one surface to the other, resulting in serious limitations. Thicker 2D batteries store more energy, but the long ion pathways result in slow charging. Thinner 2D batteries can charge faster but cannot store much energy.

“We’ve dramatically shortened the diffusion length in any direction, which takes charging to hyper-speed and delivers more power and energy storage than 2D batteries,” said Dr. Prieto, founder and chief technology officer of Prieto. “The core of our battery looks like a thin copper sponge, and the ions only have to travel from one strand to the next, a fraction of the distance in traditional 2D batteries.”

Prieto’s battery is designed to deliver five times the power density (20C discharge rate) and up to three times the energy density of conventional 2D batteries. It is customizable to any size or application, making it ideal for anything from electric vehicles to power tools, medical devices to mobile phones and small home appliances.

Simple, Cost-Effective Manufacturing

Prieto’s new battery boasts a unique manufacturing advantage because it is made from low-cost, sustainable materials with a simple and scalable process. Prieto uses a proven water-based electroplating process at room temperature and its process requires no dry rooms, clean rooms, or other expensive equipment.

“From day one I prioritized manufacturing ahead of the battery design, and I knew to reimagine the battery we would first have to simplify production to scale up quickly, efficiently, and affordably,” said Dr. Prieto.

Prieto’s current laboratory manufacturing yield rates are more than 90%.

“We now turn our focus to commercialization as we finalize plans to build our pilot manufacturing facility,” said Rosenberg. “Our high yield rates, combined with our simple and familiar manufacturing process used in many other industries, will ultimately result in much lower costs than traditional lithium-ion batteries and gives us a great degree of confidence.”

Prieto is currently in discussions for manufacturing and applications with potential partners.

About Prieto

Prieto developed a proprietary 3D interdigitated lithium-ion battery that delivers transformational performance, such as hyper-fast charging, wide temperature operations and is safe, at a competitive cost. Its battery is customizable to all shapes and sizes for use in electric vehicles, consumer electronics and commercial equipment. Prieto also patented a unique electroplating manufacturing process that uses non-toxic materials without the need for highly specialized facilities. The company was founded in 2009. Prieto’s lab and headquarters are in Fort Collins, Colorado. Visit prietobattery.com.

About Dr. Amy Prieto

Dr. Prieto is the founder and chief technology officer at Prieto. She earned her doctorate in Chemistry from the University of California, Berkeley, and completed her postdoctoral work at Harvard University. She received the Presidential Early Career Award for Scientists and Engineers for this battery technology and is recognized by the Smithsonian Institution, where her innovation is on display in its museum in Washington, D.C.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230519005396/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Askey and Canoga Perkins Announce Strategic Collaboration at MWC Barcelona to Deliver Rapid-Deploy 5G Critical Communications Solutions27.3.2026 12:00:00 CET | Press release

Askeyand Canoga Perkinsannounced at Mobile World Congress Barcelona a Global Partnership to Deliver SyncMetra® Network Connectivity Solution, combining Canoga Perkins’ software-defined, IT-operated private 5G network transport along with Askey’s carrier-grade 5G radio access technology. At MWC Barcelona 2026, Askey Computer Corporation and Canoga Perkins announced a strategic partnership to deploy Canoga Perkins' SyncMetra® Platform across enterprise and service provider markets with Askey. This partnership pairs Askey’s carrier-grade radio access capabilities with Canoga Perkins’ industry-leading time-sensitive networking (TSN) and synchronization technology, enabling customers to simplify deployment of ultra-low-latency, highly reliable network services for 5G, edge compute, industrial automation, and mission-critical enterprise applications. The partnership enables joint go-to-market efforts, integrated product offerings, and expanded access to SyncMetra through Askey’s sales channe

SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results27.3.2026 11:40:00 CET | Press release

Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.14 for the three months ended December 31, 2025, representing 133% year-over-year increase. EBITDA1, which is calculated by adding depreciation and amo

NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility27.3.2026 11:00:00 CET | Press release

NIQ’s new solution brings unprecedented clarity into package types, materials, and true consumption across markets, closing critical industry gaps NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the launch of its Packaging Strategic Planner Global (SPG) Solution, the first harmonized global platform to deliver monthly visibility into packaging performance across materials, formats, and pack configurations. As packaging innovation accelerates, many organizations continue to rely on fragmented or annual data to inform packaging decisions. The Packaging SPG Solution closes this gap by providing real-time data delivered monthly across regions, enabling brands and packaging partners to uncover trends, grow revenue, and strengthen relationships with CPG and retail partners. Key Highlights: New monthly global packaging tracking capability Coverage across 200+ categories Visibility into 30+ package types and 20 package materials 10+ markets at launch, expanding

European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards27.3.2026 08:47:00 CET | Press release

European DataWarehouse (EDW) is pleased to announce that it has been named both “Data Provider of the Year” and “Fintech Provider of the Year” at the 2026 GlobalCapital European Securitization Awards in London. The award ceremony recognises outstanding achievements in European structured finance, with winners selected by popular vote from across the industry. As defined by GlobalCapital, the programme celebrates “the very best in the market, as chosen by the market.” This latest recognition marks the sixth time that EDW has received the prestigious Data Provider of the Year award, having previously been honoured in 2019, 2022, 2023, 2024 and 2025, reaffirming its long-standing commitment to transparency, data quality and innovation in European securitisation. Prof. José Manuel González-Páramo, Chairman of EDW, later commented: “ Winning this award for the sixth time highlights the continued trust the European securitisation market places in EDW. Transparency, data quality and reliabili

Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 01:00:00 CET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye